evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

2,511 questions · 2,668 findings · 290 reviews

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 743 · 27.8%GRADE not reported 329 · 12.3%Very low 775 · 29%Low 484 · 18.1%Moderate 279 · 10.5%High 58 · 2.2%

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

All‐cause mortality at 30 days · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 30 days compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

All‐cause mortality at 5 years · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

Number of participants with Variceal rebleeding episodes at 30 days · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes number of participants with Variceal rebleeding episodes at 30 days compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

Reintervention Number of women with reintervention · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes number of participants with reintervention at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

Irreversible shunt occlusion at 5 years · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes irreversible shunt occlusion at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs transjugular intrahepatic portosystemic shunt (TIPS)

Encephalopathy · people with cirrhotic portal hypertension

It is very uncertain whether surgical portosystemic shunts changes number of participants with encephalopathy at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

All‐cause mortality · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

Serious adverse events · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes serious adverse events compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

Rebleeding · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes variceal rebleeding rate compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

Encephalopathy · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes encephalopathy compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

Ascites · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes ascites compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Surgical portosystemic shunts vs devascularisation with splenectomy

Any re‐intervention · people with hepatosplenic schistosomiasis

It is very uncertain whether surgical portosystemic shunts changes any re‐intervention compared with devascularisation with splenectomy (very low certainty).

1 finding from 1 review

Any experimental intervention (surgical or non-surgical) vs active control

Healing of osteonecrosis - improvement ('healed' or 'improved' vs 'unchanged' or 'worse') · People of any age and either sex, in any setting, with BRONJ; bisphosphonate exposure past or current; includes people with cancer and…

The review found no eligible studies for this question.

1 finding from 1 review

Drain use vs No drain

Maximal mouth opening (interincisal distance) · Adults with mandibular third molars requiring removal

Surgical drain (tube or gauze) led to higher maximum mouth opening (mean) compared with no drain; GRADE not reported.

1 finding from 1 review

Drain use vs No drain

Postoperative pain (mean) · Adults with mandibular third molars requiring removal

Surgical drain (tube or gauze) showed no clear difference in postoperative pain (mean) compared with no drain; GRADE not reported.

1 finding from 1 review